The AAO’s annual meeting will take place Nov. 3-6 at Moscone Center in San Francisco. The annual meeting will once again feature subspecialty day, named lectures, a range of sessions, skills transfer labs, and more.
For those who would like to attend the meeting virtually, refer to the AAO 2023 website (https://tinyurl.com/ynaxdcrp ) for more details.
This year’s show will include:
- Subspecialty Day (Nov. 3-Nov. 4)
Subspecialty Day will consist of eight meetings divided across seven different subspecialties, including glaucoma, neuro-ophthalmology, ocular oncology and pathology, refractive surgery, retina (two days), cornea and oculofacial plastic surgery. For detailed information on the events of each meeting, refer to the AAO 2023 website (https://tinyurl.com/zjjrxbz3 ).
- AAO 2023 Opening Session (Nov. 4, 9-10:30 am)
Hanneke van Proosdij and David Tayler, co-directors, Voices of Music, will give the 2023 Michael F. Marmor Lecture in Ophthalmology and the Arts, titled “Bach to the Future, Baroque Music in the 21st Century,” followed by a performance from Voices of Music. Eve J. Higginbotham, SM, MD, ML, will deliver the 80th Edward Jackson Memorial Lecture, titled “Striving Toward Better Eye Health Beyond Our Waiting Rooms.” The 2023 Laureate Award will be presented to H. Dunbar Hoskins, Jr., MD.
- Named Lectures
Nineteen named lectures will take place over the course of the AAO 2023 annual meeting. For a full list, see the AAO 2023 website (https://tinyurl.com/5n8dat7m ).
The AAO 2023 meeting registration includes access to many educational options, including: AAO and AAOE instruction courses, symposia, original paper sessions, Poster Theater presentations, informal poster discussions and a video program. For more original research and sessions highlighting cutting-edge science — in addition to original paper sessions and posters — the AAO recommends looking for the Late Breaking sections of Retina Subspecialty Day and Refractive Subspecialty Day. Also, the AAO recommends attending the interactive Diagnose This symposium (SYM08) or the Advanced Techniques in Oculoplastics instruction course (236).
- Skills Transfer Labs
This year’s meeting will feature 30 didactic lectures and 50 labs that make up the Skills Transfer Program. New in 2023 is the Artificial Iris Prosthesis lab (Michael Snyder, MD and Nicole Fram, MD, course directors) and Basics of Nonsurgical Periocular Rejuvenation (Aditi Mehta, MD, course director).
All lectures are included in your meeting registration, but Skill Transfer labs require the purchase of a separate lab ticket. You can view sessions in the Mobile Meeting Guide (https://tinyurl.com/bdcmn8pv ) by clicking the Program button on the homepage, then select Program Search. Choose Skills Transfer under the “Filter by Type” drop-down menu.
ADDITIONAL LEARNING EXPERIENCES
In-person registration also includes access to several non-CME educational options in the Expo:
- Academy Resource Center, where attendees can browse products in clinical education, coding, practice management and patient education. Attendees can also take a professional headshot.
- Learning Lounge, where attendees can enjoy informal group discussions facilitated by key opinion leaders. New topics begin every 15 minutes.
- Poster Theater, where attendees can meet presenters and attend moderated poster presentations led by mentors and colleagues.
- Showcase Theater, where companies give talks on their latest products and services as well as the latest technology trends. This year will feature 30-minute sessions and faster paced 18-minute TED Talks.
- Truhlsen-Marmor Museum of the Eye, where attendees can view the museum’s newest exhibit, “Doctor and Detective: History of Ophthalmic Diagnostics.”
AAOE PRACTICE MANAGEMENT PROGRAM
The American Academy of Ophthalmic Executives (AAOE) includes a program tailored specifically to the challenges faced by administrators and physician leaders. The program features expert-led courses, in-person networking with peers and valuable takeaways that can be immediately implemented in your practice. For more information, visit tinyurl.com/5n8k5x7t .
AAO 2023 will not require proof of vaccination for entry to the meeting, and mask wearing remains optional. While San Francisco does not currently have mask or vaccine requirements for public spaces, including Moscone Center, the convention center remains fully committed to the protocols and practices that have been developed since the pandemic (to learn more about health and safety measures, visit https://tinyurl.com/ypt7hy8k ).
A VIEW OF THE SHOW FLOOR
Below you will find an AAO booth preview to help you find your way around the show floor. We have invited advertisers to submit a brief company or product intro along with their booth number. — Lisa K. Feulner, MD, PhD, chief medical editor
Alcon helps people see brilliantly. As a global leader in eye care, the company offers a broad portfolio of surgical and vision-care products and serves more than 260 million people in more than 140 countries living with conditions such as cataracts, glaucoma, retinal diseases and refractive errors. Learn more at www.alcon.com .
Apellis Pharmaceuticals is a global biopharmaceutical company that leverages courageous science and creativity. The company is committed to addressing the unmet needs of patients and eye-care professionals worldwide.
Ophthalmology solutions for your most challenging cases. BVI offers a comprehensive portfolio designed to support you through your most challenging cataracts, glaucoma and retinal disease cases worldwide. See how BVI is rooted in science, driven by technology and inspired by you and the millions of patients we serve.
eSight – See New Possibilities.
Empower patients with eSight, the clinically validated, all-in-one solution for low vision patients, proven to enhance vision. Extensive research and purpose-driven design sets eSight apart. From seeing faces, advancing in school, work or resuming hobbies, eSight dramatically improves quality of life. Visit www.esightvision.com .
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.
The HEINE OMEGA 600 indirect ophthalmoscope continues to lead the market with feature and functionality; the lightest, high-end indirect ophthalmoscope worldwide; significantly better diagnostics even in dense cataracts with HEINE visionBOOST; a smart, long-lasting investment — 10-year warranty. High tech. Low weight. More to see. Easy to disinfect.
Icare USA is an advanced ophthalmic technology company and trusted partner in ocular disease management offering medical devices for retinal imaging, perimetry and tonometry.
IVERIC BIO, AN ASTELLAS COMPANY
Iveric Bio, an Astellas company, is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The company is committed to having a positive impact on patients’ lives by delivering high-quality, safe and effective treatments designed to address debilitating retinal diseases, including earlier stages of AMD.
ModMed is transforming ophthalmology by placing doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. Our on-staff physicians help lead and develop our EHR, PM and RCM software. Spend more time with patients and less time documenting with EMA’s Single-Screen Simple Eye Exam.
Simplify excellent patient care with Nextech’s ophthalmology-specific EHR and practice management solution. The industry’s only true single-page EHR layout and time-saving charting features allow you to spend more time with patients. Streamline your workflow, boost productivity and optimize financial performance with seamlessly integrated practice management.
Ocular Therapeutix is a biopharmaceutical company focused on innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel technology, Elutyx. Ocular Therapeutix has built a robust product pipeline of drug delivery solutions developed to reduce the complexity and burden of the current standard of care.
OCULUS has been setting milestones since 1895, developing best-in-class ophthalmic diagnostic devices. Explore our gold standard Pentacam AXL Wave, diverse product spectrum and the latest addition to our portfolio at our booth. Discover more at our Breakfast Symposium on Saturday, Nov. 4 — register now at bit.ly/OCULUS_Symposium .
Since 1986 OCuSOFT, most recognized for its doctor-recommended brand of eyelid cleansers, has served the ophthalmic community with a unique selection of proprietary brands, including OCuSOFT Lid Scrub Eyelid Cleansers, Retaine Tears, OCuSOFT HypoChlor and OCuSOFT Thermal 1-Touch Localized Heat Therapy. Visit the OCuSOFT booth to learn more.
Optos ultra-widefield (UWF) optomap multi-modality retinal imaging is the ONLY true UWF imaging technology — documenting up to 82% of the retina in a single capture. Thousands of peer reviewed studies confirm that optomap enables health-care professionals to detect and manage retinal pathology more effectively. optomap is revolutionizing health care, helping professionals save sight and save lives.
The Light Adjustable Lens (LAL) from RxSight is the first and only IOL that can be adjusted after cataract surgery. Patients can test drive their vision, allowing for custom, LASIK-like refractive precision and accuracy.
Sight Sciences’ OMNI Surgical System is a MIGS technology indicated to reduce IOP in adult patients with primary open-angle glaucoma. The SION Surgical Instrument is a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company’s TearCare System technology is 510(k) cleared for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction when used in conjunction with manual expression of the meibomian glands.
Thea Pharma is the US subsidiary of Théa. Its product offering is comprised of seven leading eye-care products that are regulated or approved by the FDA, including Zioptan, AcellFX, Cosopt, Cosopt PF, Azasite, Akten and Betimol, iVIZIA dry-eye drops and eyelid hygiene products, and now IYUZEH.
Leading the technology revolution in health care, Topcon offers the latest integrated solutions for enhanced care, including advanced multi-modal imaging, vendor-inclusive data management and groundbreaking remote diagnostic technology. Stop by our AAO booth to demo our latest innovations including the Maestro2 Robotic OCT/Fundus Camera.